Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-11.8%
5Y CAGR+31.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-11.8%/yr
Annual compound
5Y CAGR
+31.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$153.29M-61.9%
2024$402.10M+17.6%
2023$341.98M+53.0%
2022$223.57M+170.4%
2021$82.69M+108.5%
2020$39.66M+192.6%
2019$13.55M-